Normand Balthazard

Corporate Officer/Principal at

Origenix Technologies, Inc.

Health Technology

Consumer Durables

Finance

Profile

Normand Balthazard is the founder of CryoCath Technologies, Inc., ConjuChem, Inc., Biorthex, Inc., Intellivax International, Inc., Origenix Technologies, Inc. Former positions include President & Chief Executive Officer at BioCapital Investment Advisors, Inc. from 2002 to 2005, Co-Chief Executive Officer at Prognomix, Inc., Chairman, President, Secretary & Treasurer at Contact Image Corp.
from 2004 to 2007, and Director at Savaria Corp.
from 2003 to 2010.

Normand Balthazard active positions

Companies	Position	Start
Origenix Technologies, Inc.	Corporate Officer/Principal	-
Intellivax International, Inc. Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Develops nasal spray vaccines	Corporate Officer/Principal	-

All active positions of Normand Balthazard

Former positions of Normand Balthazard

Companies	Position	End
Prognomix, Inc. Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Develops market molecular diagnostic kits for testing of diabetes complications	Chief Executive Officer	30/09/2012
SAVARIA CORPORATION	Director/Board Member	28/02/2010
Contact Image Corp. Contact Image Corp. Commercial Printing/FormsCommercial Services Provides digital and fabric printing services	Chairman	22/03/2007
BioCapital Investment Advisors, Inc. BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody.	President	30/12/2005
Biorthex, Inc. Biorthex, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets surgical products	Corporate Officer/Principal	-

See the detail of Normand Balthazard's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Normand Balthazard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
CryoCath Technologies, Inc. CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment	Health Technology
ConjuChem, Inc. ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances	Health Technology
Savaria Corp. Savaria Corp. Other Consumer SpecialtiesConsumer Durables Designs and manufactures elevators, lifts and wheelchair accessible vans	Consumer Durables
Biorthex, Inc. Biorthex, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets surgical products	Health Technology
BioCapital Investment Advisors, Inc. BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody.	Finance
Intellivax International, Inc. Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Develops nasal spray vaccines	Health Technology
Contact Image Corp. Contact Image Corp. Commercial Printing/FormsCommercial Services Provides digital and fabric printing services	Commercial Services
Prognomix, Inc. Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Develops market molecular diagnostic kits for testing of diabetes complications	Health Technology
Origenix Technologies, Inc.